Clinical Pharmacogenomics of Antidepressant Response
Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to understand how genetic polymorphisms influence the efficacy
and side effect profiles of Paroxetine and Escitalopram for major depression treatment.
Details
Lead Sponsor:
National Health Research Institutes, Taiwan
Collaborators:
Chang Gung Memorial Hospital Mackay Memorial Hospital National Science Council, Taiwan Song-De, Taipei City Hospital, Taiwan Taipei City Hospital Taipei Medical University WanFang Hospital